Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

UPMC Ospars

Neither a doctor nor a teaching hospital

Research payments

$1,487,343

76 payments

Through program year 2025, UPMC Ospars is reported as receiving $1,487,343 in research payments, across 76 payments.

By program year

4 rows
Year Kind Amount Payments
2025 Research $21,524 11
2024 Research $1,216,970 29
2023 Research $177,955 20
2022 Research $70,894 16

Breakdown

Who paid Research payments · program years 2022–2025
  1. BeiGene, Ltd. $1,026,144 13 payments
  2. Daiichi Sankyo Inc. $260,326 5 payments
  3. Genentech, Inc. $109,555 32 payments
  4. AbbVie, Inc. $91,318 26 payments
Studies the money was for Research payments · program years 2022–2025
  1. A Phase 1/1b Open-Label Dose Escalation and Expansion Study of Bcl-2 Inhibitor BGB-11417 in Patients with Mature B-Cell Malignancies $1,026,144 13 payments
  2. Ds8201-A-U305 $260,326 5 payments
  3. Single Agent GDC 9545 VS Endocrine Monotherapy Adjuvant Treatment in HR Ebc $109,555 32 payments
  4. Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis $70,771 22 payments
  5. A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis $14,420 2 payments
  6. Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis (TRANSFORM-1) $3,112 1 payment
  7. Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis $3,015 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record